NASDAQ

Relmada Therapeutics, Inc. (RLMD)

♥ 660 Thanks from members

Live price chart, market sentiment, and community perspectives for Relmada Therapeutics, Inc. (NASDAQ: RLMD).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Dr. Gregory KatzLeadership: Jerome J. Adams (CEO)Leadership: Maged Shenouda (CFO)Holder: Perceptive AdvisorsHolder: RA Capital ManagementHolder: BlackRock, Inc.LezinnacRM-031Neurological Therapeutics#RLMD#Relmada Therapeutics#Biotech#CNS Drugs#NASDAQ Stock